{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:41:11Z","timestamp":1787020871695,"version":"build-2736575974"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"State of Texas","award":["01"],"award-info":[{"award-number":["01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Sex Differ"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acutely, testosterone (TES) and other androgens are efficacious vasodilators, both in vitro and in vivo; however, their long-term effects on arterial blood pressure (BP) remain unclear. It was hypothesized that endogenous androgens exert long-term anti-hypertensive effects on systemic BP through a combination of genomic and nongenomic effects to enhance vasodilation of the systemic vasculature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The long-term effects of endogenous TES and exogenous TES replacement therapy (TRT) on BP were studied in intact (InT) and castrated (CsX) male Sprague-Dawley (SD) and testicular-feminized male (Tfm, androgen receptor defective) rats (12\u2009weeks old). Systolic BP (tail-cuff plethysmography) was determined weekly for 15\u2009weeks in InT-control and CsX rats. Some CsX-SD rats received androgen replacement therapy at 10-15\u2009weeks with TES-enanthate (TRT; 1.75\u2009mg\/kg, 2x\/week) or DHT-enanthate (DRT; 1.00\u2009mg\/kg. 2x\/week) and a separate group of CsX-SD rats received losartan-potassium in drinking water (LST, 250\u2009mg\/L) for the entire 15\u2009week period. Expression of renin, angiotensinogen (Agt), angiotensin converting enzyme (ACE), and angiotensin II type I receptor (AT\n                      <jats:sub>1<\/jats:sub>\n                      R) mRNA in kidney and aorta were determined by real-time PCR (rt-PCR) and plasma renin levels were determined by radioimmunoassay.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There was a progressive rise in BP over 10\u2009weeks in CsX (109 \u00b1 3.3 vs. 143 \u00b1 3.5\u2009mmHg), while BP remained stable in InT-control (109 \u00b1 3.0 vs. 113 \u00b1 0.3). BP gradually declined to normal in CsX-TRT rats (113 \u00b1 1.3), while BP remained elevated in CsX (140 \u00b1 1.2) and normal in InT-control (113 \u00b1 0.3). LST prevented the development of hypertension in CsX at 10\u2009weeks (100 \u00b1 1.5 in CsX + LST vs. 143 \u00b1 3.5 in CsX). During the next 5\u2009weeks with TES-RT, BP declined in CsX-TRT (113 \u00b1 1.3) and remained lower in CsX + LST (99 \u00b1 0.4). DHT-RT reduced BP in CxS to a similar extent. In Tfm, CsX resulted in a similar rise in BP (109 \u00b1 0.7 vs. 139 \u00b1 0.4\u2009mmHg), but TRT reduced BP more rapidly and to a greater extent (106 \u00b1 2.8). rt-PCR of the kidney revealed that CsX increased expression of mRNA for renin (92%), ACE (58%), and AT\n                      <jats:sub>1<\/jats:sub>\n                      R (80%) compared to InT, while TES RT normalized expression of renin, AT1R, and ACE mRNA to levels of InT rats. Plasma renin levels exhibited changes similar to those observed for renin mRNA expression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This is the first study to examine the long-term effects of endogenous and exogenous androgens on BP in male SD and Tfm rats. These data reveal that endogenous androgens (TES) exert anti-hypertensive effects that appear to involve non-genomic and possibly genomic mechanism(s), resulting in reductions in RAS expression in the kidney and enhanced systemic vasodilation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13293-020-00324-5","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T22:02:46Z","timestamp":1598392966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Hypogonadal hypertension in male Sprague-Dawley rats is renin-angiotensin system-dependent: role of endogenous androgens"],"prefix":"10.1186","volume":"11","author":[{"given":"Andrea E.","family":"Hanson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Perusquia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2917-806X","authenticated-orcid":false,"given":"John N.","family":"Stallone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,26]]},"reference":[{"key":"324_CR1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1476-5381.2012.02036.x","volume":"167","author":"KJ Bubb","year":"2012","unstructured":"Bubb KJ, Khambata RS, Ahluwalia A. Sexual dimorphism in rodent models of hypertension and atherosclerosis. Brit J Pharmacol. 2012;167:298\u2013312.","journal-title":"Brit J Pharmacol"},{"key":"324_CR2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0039-128X(90)90058-J","volume":"55","author":"MF Kalin","year":"1990","unstructured":"Kalin MF, Zumoff B. Sex hormones and coronary disease: a review of the clinical studies. Steroids. 1990;55:330\u201352.","journal-title":"Steroids"},{"key":"324_CR3","volume-title":"The heart","author":"WB Kannel","year":"1994","unstructured":"Kannel WB, and Thom TJ. Incidence, prevalence and mortality and cardiovascular disease. In: The heart. Schlant RC, Alexander RW, New York: McGraw-Hill; 1994."},{"key":"324_CR4","first-page":"329","volume":"6","author":"KT Khaw","year":"1988","unstructured":"Khaw KT, Barrett-Connor E. Blood pressure and endogenous testosterone in men: an inverse relationship. J Hypertens. 1988;6:329\u201332.","journal-title":"J Hypertens"},{"key":"324_CR5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0002-8703(88)90099-3","volume":"116","author":"D Levy","year":"1988","unstructured":"Levy D, Kannel WB. Cardiovascular risks: new insights from Framingham. Am Heart J. 1988;116:266\u201372.","journal-title":"Am Heart J"},{"key":"324_CR6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1210\/er.2003-0005","volume":"24","author":"PY Liu","year":"2003","unstructured":"Liu PY, Death AK, Handelsman DJ. Androgens and cardiovascular disease. Endocr Rev. 2003;24:313\u201340.","journal-title":"Endocr Rev"},{"key":"324_CR7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.7326\/0003-4819-107-2-158","volume":"107","author":"FH Messerli","year":"1987","unstructured":"Messerli FH, Garavaglia GE, Schmieder RE, Sundgaard-Riise K, Nunez BD, Amodeo C. Disparate cardiovascular findings in men and women with essential hypertension. Ann Intern Med. 1987;107:158\u201361.","journal-title":"Ann Intern Med"},{"key":"324_CR8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1210\/er.2001-0025","volume":"24","author":"FCW Wu","year":"2003","unstructured":"Wu FCW, von Eckardstein A. Androgens and coronary artery disease. Endocr Rev. 2003;24:183\u2013217.","journal-title":"Endocr Rev"},{"key":"324_CR9","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1161\/01.ATV.17.10.2004","volume":"17","author":"SM Herman","year":"1997","unstructured":"Herman SM, Robinson JT, McCredie RJ, Adams MR, Boyer MJ, Celermajer DS. Androgen deprivation is associated with enhanced endothelium-dependent dilatation in adult men. Arterioscler Thromb Vasc Biol. 1997;17:2004\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"324_CR10","first-page":"1","volume":"12","author":"SG Mendoza","year":"1983","unstructured":"Mendoza SG, Zerpa A, Carrasco H, Colmenares O, Rangel A, Gartside PS, et al. Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion. Artery. 1983;12:1\u201323.","journal-title":"Artery"},{"key":"324_CR11","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1161\/01.HYP.37.5.1199","volume":"37","author":"JF Reckelhoff","year":"2001","unstructured":"Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension. 2001;37:1199\u2013208.","journal-title":"Hypertension"},{"key":"324_CR12","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1096\/fasebj.10.5.8621060","volume":"10","author":"MY Farhat","year":"1996","unstructured":"Farhat MY, Lavigne MC, Ramwell PW. The vascular protective effects of estrogen. FASEB J. 1996;10:615\u201324.","journal-title":"FASEB J"},{"key":"324_CR13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00001573-199409000-00018","volume":"9","author":"ME Mendelsohn","year":"1994","unstructured":"Mendelsohn ME, Karas RH. Estrogen and the blood vessel wall. Curr Opin Cardiol. 1994;9:619\u201326.","journal-title":"Curr Opin Cardiol"},{"issue":"Pt II","key":"324_CR14","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/01.HYP.33.1.170","volume":"33","author":"S Oparil","year":"1999","unstructured":"Oparil S. Hormones and vasoprotection. Hypertension. 1999;33(Pt II):170\u20136.","journal-title":"Hypertension"},{"key":"324_CR15","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/0002-9343(87)90642-5","volume":"83","author":"CG Chute","year":"1987","unstructured":"Chute CG, Baron JA, Plymate SR, Kiel DP, Pavia AT, Lozner EC, et al. Sex hormones and coronary artery disease. Am J Med. 1987;83:853\u20139.","journal-title":"Am J Med"},{"key":"324_CR16","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/01.ATV.6.4.418","volume":"6","author":"M Sewdarsen","year":"1986","unstructured":"Sewdarsen M, Jialal I, Vythilingum S, Desai R. Sex hormone levels in young Indian patients with myocardial infarction. Arterioscler. 1986;6:418\u201321.","journal-title":"Arterioscler."},{"issue":"2","key":"324_CR17","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/01.HYP.31.1.435","volume":"31","author":"JF Reckelhoff","year":"1998","unstructured":"Reckelhoff JF, Zhang H, Granger JP. Testosterone exacerbates hypertension and reduces pressure-natriuresis in male spontaneously hypertensive rats. Hypertension. 1998;31(2):435\u20139.","journal-title":"Hypertension"},{"key":"324_CR18","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/00004872-198909000-00005","volume":"7","author":"U Ganten","year":"1989","unstructured":"Ganten U, Schr\u00f6der G, Witt M, Zimmermann F, Ganten D, Stock G. Sexual dimorphism of blood pressure in spontaneously hypertensive rats: effects of anti androgen treatment. J Hypertens. 1989;7:721\u20136.","journal-title":"J Hypertens"},{"key":"324_CR19","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.HYP.29.1.494","volume":"29","author":"JT Crofton","year":"1997","unstructured":"Crofton JT, Share L. Gonadal hormones modulate deoxycorticosterone-hypertension in male and female rats. Hypertension. 1997;29:494\u20139.","journal-title":"Hypertension"},{"key":"324_CR20","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/01.HYP.34.4.920","volume":"34","author":"JF Reckelhoff","year":"1999","unstructured":"Reckelhoff JF, Zhang H, Srivastava K, Granger JP. Gender differences in hypertension in spontaneously hypertensive rats. Role of androgens and androgen receptor. Hypertension. 1999;34:920\u20133.","journal-title":"Hypertension"},{"key":"324_CR21","first-page":"997","volume":"90","author":"SG Iams","year":"1977","unstructured":"Iams SG, Wexler BC. Retardation in the development of spontaneous hypertension in SH rats by gonadectomy. J Lab Clin Med. 1977;90:997\u20131003.","journal-title":"J Lab Clin Med"},{"issue":"7","key":"324_CR22","first-page":"1249","volume":"11","author":"JT Crofton","year":"1989","unstructured":"Crofton JT, Share L, Brooks DP. Gonadectomy abolishes the sexual dimorphism in DOC-salt hypertension in the rat. Clin Exp Hypertens. 1989;11(7):1249\u201361.","journal-title":"Clin Exp Hypertens"},{"key":"324_CR23","doi-asserted-by":"crossref","first-page":"F771","DOI":"10.1152\/ajprenal.90389.2008","volume":"296","author":"LL Yanes","year":"2009","unstructured":"Yanes LL, Sartori-Valinotti JC, Iliescu R, Romero DG, Racusen LC, Zhang H, et al. Testosterone-dependent hypertension and upregulation of intrarenal angiotensinogen in dahl salt-sensitive rats. Am J Physiol Ren Physiol. 2009;296:F771\u20139.","journal-title":"Am J Physiol Ren Physiol"},{"key":"324_CR24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1210\/jcem-2-5-325","volume":"2","author":"L Hamm","year":"1942","unstructured":"Hamm L. Testosterone propionate in the treatment of angina pectoris. J Clin Endocrinol. 1942;2:325\u20138.","journal-title":"J Clin Endocrinol"},{"key":"324_CR25","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1210\/jcem-6-8-549","volume":"6","author":"MA Lesser","year":"1946","unstructured":"Lesser MA. Testosterone propionate therapy in one hundred cases of angina pectoris. J Clin Endocrinol. 1946;6:549\u201357.","journal-title":"J Clin Endocrinol"},{"key":"324_CR26","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1210\/jcem-2-9-560","volume":"2","author":"TC Walker","year":"1942","unstructured":"Walker TC. Use of testosterone propionate and estrogenic substance in treatment of essential hypertension, angina pectoris, and peripheral vascular disease. J Clin Endocrinol. 1942;2:560\u20138.","journal-title":"J Clin Endocrinol"},{"key":"324_CR27","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJM193905252202103","volume":"220","author":"E Edwards","year":"1939","unstructured":"Edwards E, Hamilton J, Duntley S. Testosterone propionate as a therapeutic agent in patients with organic disease of peripheral vessels. New Engl J Med. 1939;220:865\u20139.","journal-title":"New Engl J Med"},{"key":"324_CR28","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1136\/hrt.39.11.1217","volume":"39","author":"MD Jaffe","year":"1977","unstructured":"Jaffe MD. Effect of testosterone cypionate on postexercise ST segment depression. Br Heart J. 1977;39:1217\u201322.","journal-title":"Br Heart J"},{"key":"324_CR29","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1161\/01.CIR.99.13.1666","volume":"99","author":"GMC Rosano","year":"1999","unstructured":"Rosano GMC, Leonardo F, Pagnotta P, Pelliccia F, Panina G, Cerquetani E, et al. Acute anti-ischemic effect of testosterone in men with coronary artery disease. Circulation. 1999;99:1666\u201370.","journal-title":"Circulation"},{"key":"324_CR30","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/01.CIR.100.16.1690","volume":"100","author":"CM Webb","year":"1999","unstructured":"Webb CM, McNeill JG, Hayward CS, de Zeigler D, Collins P. Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. Circulation. 1999;100:1690\u20136.","journal-title":"Circulation"},{"key":"324_CR31","doi-asserted-by":"crossref","first-page":"H1301","DOI":"10.1152\/ajpheart.00753.2009","volume":"298","author":"M Perusqu\u00eda","year":"2010","unstructured":"Perusqu\u00eda M, Stallone JN. Do androgens play a beneficial role in the regulation of vascular tone? Nongenomic vascular effects of testosterone metabolites. Am J Physiol Heart Circ Physiol. 2010;298:H1301\u20137.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"324_CR32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000176047","volume":"37","author":"JE Nettleship","year":"2009","unstructured":"Nettleship JE, Jones RD, Channer KS, Jones TH. Testosterone and coronary artery disease. Front Horm Res. 2009;37:91\u2013107.","journal-title":"Front Horm Res"},{"key":"324_CR33","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1161\/01.CIR.94.10.2614","volume":"94","author":"TM Chou","year":"1996","unstructured":"Chou TM, Sudhir K, Hutchison SJ, Ko E, Amidon TM, Collins P, et al. Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation. 1996;94:2614\u20139.","journal-title":"Circulation"},{"key":"324_CR34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1113\/jphysiol.2002.022756","volume":"543","author":"C Molinari","year":"2002","unstructured":"Molinari C, Battaglia A, Grossini E, Mary DA, Vassanelli C, Vacca G. The effect of testosterone on regional blood flow in prepubertal anaesthetized pigs. J Physiol. 2002;543:365\u201372.","journal-title":"J Physiol"},{"key":"324_CR35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1113\/jphysiol.2004.063354","volume":"557","author":"C Molinari","year":"2004","unstructured":"Molinari C, Battaglia A, Grosinni E, Mary DA, Vassanelli C, Vaca G. The effects of dehydroepiandrosterone in regional blood flow in prepubertal anesthetized pigs. J Physiol. 2004;557:307\u201319.","journal-title":"J Physiol"},{"key":"324_CR36","doi-asserted-by":"crossref","first-page":"R189","DOI":"10.1152\/ajpregu.00110.2015","volume":"309","author":"M Perusquia","year":"2015","unstructured":"Perusquia M, Greenway CD, Perkins LM, Stallone JN. Systemic hypotensive effects of testosterone are androgen structure-specific and neuronal nitric oxide synthase-dependent. Am J Physiol Regul Integ Compar Physiol. 2015;309:R189\u201395.","journal-title":"Am J Physiol Regul Integ Compar Physiol"},{"key":"324_CR37","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1152\/jappl.2001.91.6.2742","volume":"91","author":"AQ Ding","year":"2001","unstructured":"Ding AQ, Stallone JN. Testosterone-induced relaxation of rat aorta is androgen structure specific and involves K+ channel activation. J Appl Physiol. 2001;91:2742\u201350.","journal-title":"J Appl Physiol"},{"key":"324_CR38","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.lfs.2007.07.024","volume":"81","author":"M Perusqu\u00eda","year":"2007","unstructured":"Perusqu\u00eda M, Navarrete E, Gonzalez L, Villal\u00f3n CM. The modulatory role of androgens and progestins in the induction of vasorelaxation in human umbilical artery. Life Sci. 2007;81:993\u20131002.","journal-title":"Life Sci"},{"key":"324_CR39","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0039-128X(02)00061-2","volume":"67","author":"M Perusqu\u00eda","year":"2002","unstructured":"Perusqu\u00eda M, Villal\u00f3n CM. The vasodepressor effect of androgens in pithed rats: potential role of calcium channels. Steroids. 2002;67:1021\u20138.","journal-title":"Steroids"},{"key":"324_CR40","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1161\/01.CIR.91.4.1154","volume":"91","author":"P Yue","year":"1995","unstructured":"Yue P, Chatterjee K, Beale C, Poole-Wilson PA, Collins P. Testosterone relaxes rabbit coronary arteries and aorta. Circulation. 1995;91:1154\u201360.","journal-title":"Circulation"},{"issue":"4","key":"324_CR41","doi-asserted-by":"crossref","first-page":"H1542","DOI":"10.1152\/ajpheart.01024.2004","volume":"289","author":"M Li","year":"2005","unstructured":"Li M, Stallone JN. Estrogen potentiates vasopressin-induced contraction of female rat aorta by enhancing cyclooxygenase-2 and thromboxane function. Am J Physiol Heart Circ Physiol. 2005;289(4):H1542\u201350.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"324_CR42","first-page":"430","volume":"29","author":"AJ Stanley","year":"1973","unstructured":"Stanley AJ, Gumbreck LG, Allison JE, Easley RB. Part I. male pseudohermaphro-ditism in the laboratory Norway rat. Recent Prog Horm Res. 1973;29:430\u201364.","journal-title":"Recent Prog Horm Res"},{"issue":"4454","key":"324_CR43","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1126\/science.7384816","volume":"209","author":"BH Shapiro","year":"1980","unstructured":"Shapiro BH, Levine DC, Adler NT. The testicular feminized rat: a naturally occurring model of androgen independent brain masculinization. Science. 1980;209(4454):418\u201320.","journal-title":"Science"},{"issue":"15","key":"324_CR44","doi-asserted-by":"crossref","first-page":"8893","DOI":"10.1016\/S0021-9258(19)38972-0","volume":"265","author":"WG Yarbrough","year":"1990","unstructured":"Yarbrough WG, Quarmby VE, Simental JA, Joseph DR, Sar M, Lubahn DB, et al. A single base mutation in the androgen receptor gene causes androgen insensitivity in the testicular feminized rat. J Biol Chem. 1990;265(15):8893\u2013900.","journal-title":"J Biol Chem"},{"key":"324_CR45","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1152\/jappl.2001.91.6.2602","volume":"91","author":"JN Stallone","year":"2001","unstructured":"Stallone JN, Salisbury RL, Fulton CT. Androgen receptor defect abolishes sex differences in nitric oxide and reactivity to vasopressin in rat aorta. J Appl Physiol. 2001;91:2602\u201310.","journal-title":"J Appl Physiol"},{"issue":"1","key":"324_CR46","first-page":"34","volume":"277","author":"CE Costarella","year":"1996","unstructured":"Costarella CE, Stallone JN, Rutecki GW, Whittier FC. Testosterone causes direct relaxation of rat thoracic aorta. J Pharmacol Exp Ther. 1996;277(1):34\u20139.","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"324_CR47","first-page":"491","volume":"56","author":"GP Boivin","year":"2017","unstructured":"Boivin GP, Hickman DL, Creamer-Hente MA, Pritchett-Corning KR, Bratcher NA. Review of CO2 as a euthanasia agent for laboratory rats and mice. J Am Assoc Lab Anim Sci. 2017;56(5):491\u20139.","journal-title":"J Am Assoc Lab Anim Sci"},{"issue":"10","key":"324_CR48","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/15592294.2017.1363952","volume":"12","author":"RC Chang","year":"2017","unstructured":"Chang RC, Skiles WM, Chronister SS, Wang H, Sutton GI, Bedi YS, et al. DNA methylation-independent growth restriction and altered developmental programming in a mouse model of preconception male alcohol exposure. Epigenetics. 2017;12(10):841\u201353.","journal-title":"Epigenetics"},{"key":"324_CR49","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jsbmb.2016.11.016","volume":"167","author":"M Perusquia","year":"2017","unstructured":"Perusquia M, Herrera N, Ferrer M, Stallone JN. Antihypertensive effects of androgens in conscious, spontaneously hypertensive rats. J Steroid Biochem Mol Biol. 2017;167:106\u201314.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"324_CR50","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s12020-019-01978-x","volume":"65","author":"M Perusquia","year":"2019","unstructured":"Perusquia M, Contreras D, Herrera N. Hypotestosteronemia is an important factor for the development of hypertension: elevated blood pressure in orchidectomized conscious rats is reversed by different androgens. Endocrine. 2019;65(2):416\u201325.","journal-title":"Endocrine"},{"key":"324_CR51","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/0039-128X(94)90022-1","volume":"59","author":"K Iki","year":"1994","unstructured":"Iki K, Miyamori I, Hatakeyama H, Yoneda T, Takeda Y, Takeda R, et al. The activities of 5 beta-reductase and 11 beta-hydroxysteroid dehydrogenase in essential hypertension. Steroids. 1994;59:656\u201360.","journal-title":"Steroids"},{"key":"324_CR52","doi-asserted-by":"crossref","unstructured":"Hanson AE, Garcia NW, McKenna JM, Perusquia M, Stallone JN. Hypotestosteronemia-induced hypertension in male Sprague-Dawley rats is reversed by testosterone replacement therapy, which is a non-genomic, estrogen-independent effect. FASEB J. 2018;32(1):584.9.","DOI":"10.1096\/fasebj.2018.32.1_supplement.584.9"},{"issue":"9","key":"324_CR53","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0026-0495(99)90123-3","volume":"48","author":"M-M Kau","year":"1999","unstructured":"Kau M-M, Lo M-J, Wang S-W, Tsai S-C, Chen J-J, Chiao Y-C, et al. Inhibition of aldosterone production by testosterone in male rats. Metabolism. 1999;48(9):1108\u201314.","journal-title":"Metabolism"},{"issue":"1","key":"324_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.190101ufm","volume":"33","author":"L Fan","year":"2019","unstructured":"Fan L, Kudo L, Rouch A. Testosterone reduces mRNA expression of renal sodium transporters but does not affect blood pressure during a ten-day angiotensin II infusion period in castrated mice. FASEB J. 2019;33(1):1.","journal-title":"FASEB J"},{"key":"324_CR55","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1177\/41.5.8468448","volume":"41","author":"N Kimura","year":"1993","unstructured":"Kimura N, Mizokami A, Oonuma T, Sasano H, Nagura H. Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissues. J Histochem Cytochem. 1993;41:671\u20138.","journal-title":"J Histochem Cytochem"},{"issue":"287","key":"324_CR56","doi-asserted-by":"crossref","first-page":"F452","DOI":"10.1152\/ajprenal.00188.2003","volume":"2004","author":"A Quan","year":"2004","unstructured":"Quan A, Chakravarty S, Chen JK, Chen JC, Loleh S, Saini N, et al. Androgens augment proximal tubule transport. Am J Physiol Ren Physiol. 2004;2004(287):F452\u20139.","journal-title":"Am J Physiol Ren Physiol"},{"key":"324_CR57","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1210\/jc.2002-021970","volume":"88","author":"M Quinkler","year":"2003","unstructured":"Quinkler M, Bumke-Vogt C, Meyer B, Bahr V, Oelkers W, Diederich S. The human kidney is a progesterone-metabolizing and androgen-producing organ. J Clin Endocrinol Metab. 2003;88:2803\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"324_CR58","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0039-128X(97)00142-6","volume":"63","author":"K Matsuzaki","year":"1998","unstructured":"Matsuzaki K, Arai T, Inumaru T, Mihori M, Momose T, Sano M, et al. Androgen metabolism in cultured rat renal inner medullary collecting duct (IMCD) cells. Steroids. 1998;63:105\u201310.","journal-title":"Steroids"},{"key":"324_CR59","first-page":"2402","volume":"2017","author":"A Bulldan","year":"1864","unstructured":"Bulldan A, Malviya VN, Upmanyu N, Konrad L, Scheiner-Bobis G. Testosterone\/bicalutamide antagonism at the predicted extracellular androgen binding site of ZIP9. BBA-Mol Cell Res. 1864;2017:2402\u201314.","journal-title":"BBA-Mol Cell Res"},{"issue":"2","key":"324_CR60","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1210\/en.2017-00718","volume":"159","author":"N Peinetti","year":"2018","unstructured":"Peinetti N, Scalerandi MV, Rubio MMC, Leimgruber C, Nicola JP, Torres AI, et al. The response of prostate smooth muscle cells to testosterone is determined by the subcellular distribution of the androgen receptor. Endocrinology. 2018;159(2):945\u201356.","journal-title":"Endocrinology"},{"issue":"6","key":"324_CR61","first-page":"532","volume":"107","author":"L Chodari","year":"2016","unstructured":"Chodari L, Mohammadi M, Mohaddes G, Alipour MR, Ghorbanzade V, Dariushnejad H, et al. Testosterone and voluntary exercise, alone or together increase cardiac activation of AKT and ERK1\/2 in diabetic rats. Arq Bras Cardiol. 2016;107(6):532\u201341.","journal-title":"Arq Bras Cardiol"},{"issue":"3","key":"324_CR62","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.3892\/mmr.2016.5562","volume":"14","author":"J Zhao","year":"2016","unstructured":"Zhao J, Liu GL, Wei Y, Jiang LH, Bao PL, Yang QY. Low-dose testosterone alleviates vascular damage caused by castration in male rats in puberty via modulation of the PI3K\/AKT signaling pathway. Mol Med Rep. 2016;14(3):2518\u201326.","journal-title":"Mol Med Rep"},{"issue":"5","key":"324_CR63","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1177\/1074248417691136","volume":"22","author":"AM Traish","year":"2017","unstructured":"Traish AM, Haider A, Haider KS, Doros G, Saad F. Long-term testosterone therapy improves cardiometabolic function and reduces risk of cardiovascular disease in men with hypogonadism: a real-life observational registry study setting comparing treated and untreated (control) groups. J Cardiovasc Pharmacol Therap. 2017;22(5):414\u201333.","journal-title":"J Cardiovasc Pharmacol Therap"},{"key":"324_CR64","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1291\/hypres.28.625","volume":"28","author":"R Fogari","year":"2005","unstructured":"Fogari R, Preti P, Zoppi A, Fogari E, Rinaldi A, Corradi L, et al. Serum testosterone levels and arterial blood pressure in the elderly. Hypertens Res. 2005;28:625\u201330.","journal-title":"Hypertens Res"},{"key":"324_CR65","first-page":"991","volume":"16","author":"P M\u00e5rin","year":"1992","unstructured":"M\u00e5rin P, Holm\u00e4ng S, J\u00f6nsson L, Sj\u00f6str\u00f6m L, Kvist H, Holm G, et al. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord. 1992;16:991\u20137.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"324_CR66","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00004872-198903000-00003","volume":"7","author":"GS Hughes","year":"1989","unstructured":"Hughes GS, Mathur RS, Margolius HS. Sex steroid hormones are altered in essential hypertension. J Hypertens. 1989;7:181\u20137.","journal-title":"J Hypertens"},{"key":"324_CR67","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00004872-199307000-00003","volume":"11","author":"GB Phillips","year":"1993","unstructured":"Phillips GB, Jing TY, Resnick LM, Barbagallo M, Laragh JH, Sealey JE. Sex hormones and hemostatic risk factors for coronary heart disease in men with hypertension. J Hypertens. 1993;11:699\u2013702.","journal-title":"J Hypertens"},{"key":"324_CR68","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1530\/eje.0.1500065","volume":"150","author":"J Svartberg","year":"2004","unstructured":"Svartberg J, von M\u00fchlen D, Schirmer H, Barrett-Connor E, Sundfjord J, Jorde R. Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Tromso study. Eur J Endocrinol. 2004;150:65\u201371.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"324_CR69","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.mayocp.2014.10.011","volume":"90","author":"A Morgentaler","year":"2015","unstructured":"Morgentaler A, Miner MM, Caliber M, Guay AT, Khera M, Traish AM. Testosterone therapy and cardiovascular risk: advances and controversies. Mayo Clin Proc. 2015;90(2):224\u201351.","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"324_CR70","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.mayocp.2016.04.007","volume":"91","author":"A Morgentaler","year":"2016","unstructured":"Morgentaler A, Zitmann M, Traish AM. Fundamental concepts regarding testosterone deficiency and treatment: international expert consensus resolutions. Mayo Clin Proc. 2016;91(7):881\u201396.","journal-title":"Mayo Clin Proc"}],"container-title":["Biology of Sex Differences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-020-00324-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13293-020-00324-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-020-00324-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T19:56:09Z","timestamp":1629921369000},"score":1,"resource":{"primary":{"URL":"https:\/\/bsd.biomedcentral.com\/articles\/10.1186\/s13293-020-00324-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,26]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["324"],"URL":"https:\/\/doi.org\/10.1186\/s13293-020-00324-5","relation":{},"ISSN":["2042-6410"],"issn-type":[{"value":"2042-6410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,26]]},"assertion":[{"value":"26 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Animal Use Protocol for these studies was written in accordance with regulations of the Office of Laboratory Animal Welfare (OLAW) of the National Institutes of Health (NIH), and were reviewed and approved by the Texas A&M University Institutional Animal Care and Use Committee (IACUC).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have consented to publication of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}